OTC Diagnostics Forecast: Growing With Pandemic But High Bar For Approval Could Slow Spread

Sample-collection kit and testing firms acknowledge regulatory approval for OTC sales can be as complicated as the technology behind their products. But consumers have OTC access to numerous at-home collection kits for tests for indications of diseases or medical conditions as well as for genealogy. Kits approved for testing for influenzas or other infections also should become available OTC, say industry stakeholders.

Pixel is the first at-home collection kit for COVID-19 allowed for OTC distribution in the US nearly a year after national health emergency was declared due to the pandemic.

More from Regulation

More from Policy & Regulation